Author: Saleemi, Mansab Ali; Ahmad, Bilal; Benchoula, Khaled; Vohra, Muhammad Sufyan; Mea, Hing Jian; Chong, Pei Pei; Palanisamy, Navindra Kumari; Wong, Eng Hwa
Title: Emergence and molecular mechanisms of SARS-CoV-2 and HIV to target host cells and potential therapeutics Cord-id: g28sx9qu Document date: 2020_10_6
ID: g28sx9qu
Snippet: The emergence of a new coronavirus, in around late December 2019 which had first been reported in Wuhan, China has now developed into a massive threat to global public health. The World Health Organization (WHO) has named the disease caused by the virus as COVID-19 and the virus which is the culprit was renamed from the initial novel respiratory 2019 coronavirus to SARS-CoV-2. The person-to-person transmission of this virus is ongoing despite drastic public health mitigation measures such as soc
Document: The emergence of a new coronavirus, in around late December 2019 which had first been reported in Wuhan, China has now developed into a massive threat to global public health. The World Health Organization (WHO) has named the disease caused by the virus as COVID-19 and the virus which is the culprit was renamed from the initial novel respiratory 2019 coronavirus to SARS-CoV-2. The person-to-person transmission of this virus is ongoing despite drastic public health mitigation measures such as social distancing and movement restrictions implemented in most countries. Understanding the source of such an infectious pathogen is crucial to develop a means of avoiding transmission and further to develop therapeutic drugs and vaccines. To identify the etiological source of a novel human pathogen is a dynamic process that needs comprehensive and extensive scientific validations, such as observed in the Middle East respiratory syndrome (MERS), severe acute respiratory syndrome (SARS), and human immunodeficiency virus (HIV) cases. In this context, this review is devoted to understanding the taxonomic characteristics of SARS-CoV-2 and HIV. Herein, we discuss the emergence and molecular mechanisms of both viral infections. Nevertheless, no vaccine or therapeutic drug is yet to be approved for the treatment of SARS-CoV-2, although it is highly likely that new effective medications that target the virus specifically will take years to establish. Therefore, this review reflects the latest repurpose of existing antiviral therapeutic drug choices available to combat SARS-CoV-2.
Search related documents:
Co phrase search for related documents- absence presence and accurate reliable: 1
- absence presence and acute ards respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- absence presence and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
- absence presence and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35
- absence presence and additional activity: 1
- absence presence and additional gene: 1, 2, 3
- absence presence and lopinavir plus ritonavir: 1
- absence presence and lopinavir ritonavir: 1, 2
- absence presence and lung lesion: 1, 2, 3
- absence presence and lymph node: 1, 2, 3, 4, 5
- absence presence and macaque model: 1, 2
- accession number and acute respiratory syndrome: 1, 2, 3
- accession number and acute sars cov respiratory syndrome coronavirus: 1, 2, 3
- accession number and additional gene: 1
- accession number and lymph node: 1, 2
- accessory gene and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8
- accessory gene and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4
- accessory protein and acute ards respiratory distress syndrome: 1
- accessory protein and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35
Co phrase search for related documents, hyperlinks ordered by date